InvestorsHub Logo
Followers 27
Posts 3416
Boards Moderated 0
Alias Born 07/17/2006

Re: None

Wednesday, 03/16/2016 1:41:52 PM

Wednesday, March 16, 2016 1:41:52 PM

Post# of 346282
Another annoying reality. The anti-PS theoretical discussion is diverting but the only science that matters for a business like Peregrine Pharmaceuticals is what that science does for people in the clinics.

So far, Bavi has not done enough in the clinic to attract a partner or keep our share price above a dollar.

Peregrine needs to show us how they can get clinical results in less than a year that will get our share price back over a dollar preventing the necessity of a reverse split.

I did not harp on the reverse split line with the share price floating slightly above a dollar. However, at 40 cents the RS clock is definitely ticking.

Management needs to move swiftly in any way they can to prevent another disastrous RS. Slash expenses, boost Avid revenue, rent out the parking lot. I don't care how they do it, but they have to find a way to convince investors they know how to run a business without endless infusions of cash.

GLTA, Paul
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News